While the relationship between SMARCB1 mutations and glioblastoma prognosis is not well researched, SMARCB1 loss has been identified in several rare pediatric and adult cancers, termed SMARCB1-deficient cancers, most of which have a poor prognosis [114]. This evidence concerns the gene SMARCB1 and cancer.